CNIM group announced revenue results for the third quarter and nine months ended September 30, 2018. For the quarter, the company reported revenue of EUR 141.6 million compared to EUR 151.6 million a year ago.

For the nine months, the company reported revenue of EUR 464.1 million compared to EUR 411.5 million a year ago.

In view of the acquisitions of Exensor and Winlight Companies and the disposal of the Bertin Pharma business transactions, the net profit for 2018 will increase significantly compared with 2017.